Medical/Pharmaceuticals

INTREPID Alliance Launches Antiviral Toolbox to Support Global Research Community

Open-access resource includes Registry of Antiviral Compound Libraries to help catalyze drug discovery for priority viruses of pandemic and endemic concern CAMBRIDGE, Mass., Nov. 5, 2025 /PRNewswire/ -- The INTREPID Alliance today announced the launch of theAntiviral Toolbox, an open-access resou...

2025-11-05 02:20 857

Metabolon Powers Largest-Ever Veteran Metabolomics Study with Global Discovery Panel

Metabolon to Support Landmark Million Veteran Program 62,000-sample Dataset AdvancingVeteran Health and Multiomics Research MORRISVILLE, N.C., Nov. 4, 2025 /PRNewswire/ -- Metabolon ...

2025-11-04 22:00 768

Grit Biotherapeutics Invited to Deliver Oral Presentation at ASH 2025 on Breakthrough In Vivo CAR-T Therapy GT801

BEIJING, Nov. 4, 2025 /PRNewswire/ -- Grit Biotherapeutics Co., Ltd. ("Grit Bio "), a leading clinical-stage biopharmaceutical company pioneering next-generation immunotherapies,today announced that its groundbreaking GT801 in vivo CAR-T program has been selected for an oral presentation at the u...

2025-11-04 21:15 1354

LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction

BEIJING, Nov. 4, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics fo...

2025-11-04 20:04 1876

Sky Labs Attracts Investment With Omron Subsidiary 'OMRON VENTURES'

Global blood pressure monitoring No. 1 OMRON Healthcare signs strategic partnership MoU SEOUL, South Korea, Nov. 4, 2025 /PRNewswire/ -- On November 4, 2025, Sky Labs announced that it had attracted investments with OMRON Ventures(OVC: Minato-ku, Tokyo), Omron Group's enterprise-led venture capit...

2025-11-04 19:25 972

Elevaris Introduces CDMO Services, Procedural Needle Portfolio to EMEA

Company Leverages Legacy of Trust and Expertise as it Makes Inaugural Appearance at COMPAMED/MEDICA BOSTON, Nov. 4, 2025 /PRNewswire/ -- Elevaris Medical Devices, the world-class Contract Development and Manufacturing Organization resulting from the acquisition of UK-based XL Precision Technolog...

2025-11-04 17:00 695

Healthcare Holding Schweiz Acquires a Stake in QUNIQUE

Healthcare Holding Schweiz AG, a leading provider of medical technology services and distribution solutions inSwitzerland, has expanded its portfolio through the acquisition of a stake in QUNIQUE GmbH. Healthcare Holding Schweiz is managed by Winterberg Advisory GmbH and KKA Partners. BAAR, Swit...

2025-11-04 16:00 954

NCCN Celebrates Expanding Access to Cancer Treatment in Africa at 2025 AORTIC Meeting with New NCCN Adaptations for Sub-Saharan Africa

Updated cancer treatment guidelines reflect significant progress in cancer care delivery through ongoing collaborative efforts to strengthen oncology resources across the region. HAMMAMET, Tunisia, Nov. 4, 2025 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of lea...

2025-11-04 15:06 830

Hasten Sets a New Benchmark for Global Expansion‌ by Building an End-to-End Asia-Pacific Healthcare Commercial Platform

SHANGHAI, Nov. 4, 2025 /PRNewswire/ -- Hasten Biopharmaceutical Co., Ltd. ("Hasten") announced that while completing 70 Marketing Authorization Transfers (MAT) for itsAsia-Pacific product portfolio, the company has established an end-to-end commercial network coveringSoutheast Asia, Australia, Ko...

2025-11-04 11:15 1037

Oral Presentation: Five Hematologic Malignancies Studies by Leads Biolabs to Be Featured at ASH 2025

NANJING, China, Nov. 4, 2025 /PRNewswire/ -- Leads Biolabs (Stock Code: 9887.HK) today announced that five research abstracts from its hematological oncology portfolio—including programs LBL–034 and LBL–076—have been accepted for presentation at the 67th Annual Meeting of the American Society of ...

2025-11-04 09:50 1013

CQ Medical® Appoints Michael Galbus as Chief Executive Officer, Mike Sutter as Chairman of the Board of Directors

AVONDALE, Pa., Nov. 4, 2025 /PRNewswire/ -- CQ Medical is pleased to announce the appointment ofMichael Galbus as Chief Executive Officer. Michael previously served as Chief Operating Officer, where he played a key role in enhancing operational performance, advancing the company's growth strategy...

2025-11-04 02:00 1035

CARsgen Announces Positive Clinical Data for Allogeneic CAR-T Products CT0596 and CT1190B

SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces clinical data for CT0596, an allogeneic BCMA-targeting CAR-T product candidate developed on its proprietary THANK-u Plus™ ...

2025-11-03 22:15 1648

EmeTerm Wristband Significantly Reduces Postoperative Nausea and Vomiting in Major Orthopedic Surgeries

VANCOUVER, BC, Nov. 3, 2025 /PRNewswire/ -- WAT Medical Enterprise Ltd. proudly announced the publication of a groundbreaking clinical trial inThe Journal of Bone & Joint Surgery (JBJS) which demonstrates the significant benefits of the EmeTerm wristband in reducing postoperative nausea and vomit...

2025-11-03 22:00 1066

Sanyou Bio and Shanghai ZJ Bio-Tech Sign Strategic Cooperation Agreement on Automated Development of Innovative Biologics to Jointly Tackle R&D Bottlenecks and Provide New Momentum for Innovative Drug R&D

SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Shanghai ZJ Bio-Tech technology Co., Ltd. (hereinafter referred to as "Shanghai ZJ Bio-Tech") jointly announced the official signing of a strategic cooperation agree...

2025-11-03 22:00 1630

Samsung Biologics completes spin-off to strengthen its focus as a pure-play CDMO

* Spin-off finalized within five months following board resolution * Proposal approved in shareholders' meeting with 99.9% support * Company to reaffirm its identity as a pure-play CDMO INCHEON, South Korea, Nov. 3, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) today announced the ...

2025-11-03 20:00 1155

TCT 2025 | Robot-Assisted PCI Enters a New Era: Results of the PANVIS STAR Multicenter Randomized Controlled Trial

SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- The 37th Annual Transcatheter Cardiovascular Therapeutics (TCT2025) symposium was held grandly inSan Francisco ,USA, attracting widespread attention from the global cardiovascular community. On the morning ofOctober 28th (local time), during the "Innovation S...

2025-11-03 18:04 1283

Anthill Cloud: Transforming Pharma Marketing with AI, Modular Content, and Omnichannel Engagement

COPENHAGEN, Denmark, Nov. 3, 2025 /PRNewswire/ -- Anthill , a leading content excellence and technology partner to the life sciences industry, has announced the launch ofAnthill Cloud™ — an innovative platform that combines AI, modular content, and personalized e...

2025-11-03 17:00 1118

Novo Nordisk Launches Wegovy® in Hong Kong for Weight Management

* Wegovy® (semaglutide) is a once-weekly injectable prescription medicine used in combination with a reduced calorie diet and increased physical activity for adults and adolescents aged 12 years old or above with obesity or adults with overweight in the presence of at least one related health c...

2025-11-03 16:48 1160

Sandstone Easydrip™ Plus with Hextra Tech™ Hexagonal Broad Hub Delivers Steadier, More Comfortable Insulin Injections

SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- A peer-reviewed article by researchers at the University ofShanghai for Science and Technology (USST), published in an international biomedical engineering journal, reports that the Hextra Tech™ hexagonal, broad-platform hub used in Sandstone Easydrip™ Plus ...

2025-11-03 14:35 901

Johnson & Johnson Showcases Latest Advancements in Pulsed Field Ablation with Multiple Clinical and Real-world Studies at APHRS and JPHRS

Key oral presentations highlight new safety, efficacy and workflow improvements data to optimize irrigation and support consistent procedural outcomes. YOKOHAMA, Japan, Nov. 3, 2025 /PRNewswire/ -- Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment1, today announced th...

2025-11-03 14:35 1097
1 ... 14151617181920 ... 644

Week's Top Stories